Gyre Therapeutics (GYRE) Financials: Revenue & Earnings
$747.97M
Market Cap
—
P/E
—
Forward P/E
58
Score
GYRE price $7.05 +0.52 +8.03%
Stocklytics score rationale: value 59, quality 33, growth 83.
GYRE fair value $35.42. Price $7.05. Price is 80% below fair value.
Above fair value, and more expensive than usual. A larger premium than on 71% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 17.78M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 106.03M. Net debt -36.13M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-06 | — | -0.15 | — | 28.40M |
| 2026-08-07 | -0.12 | -0.06 | 29.11M | 26.49M |
| 2026-05-07 | -0.05 | -0.06 | 22.52M | 31.61M |
| 2026-03-12 | -0.02 | 0.06 | 37.20M | 35.43M |
| 2025-11-07 | 0.06 | 0.05 | 30.56M | 32.93M |
| 2025-08-11 | 0.02 | 0.03 | 26.77M | 30.80M |
| 2025-05-09 | 0.03 | 0.03 | 22.06M | 28.40M |
| 2025-03-17 | 0.01 | 0.04 | 27.87M | 23.50M |
| 2024-11-14 | 0.01 | — | 25.49M | 113.45M |
| 2024-08-13 | 0.01 | — | 25.23M | 113.45M |
| 2024-05-09 | 0.03 | — | 27.17M | — |
| 2024-03-28 | -1.39 | -0.60 | 27.15M | 113.45M |
| 2023-10-26 | -1.05 | -0.75 | 32.04M | — |
| 2023-08-14 | -1.05 | -1.05 | 29.33M | — |
| 2023-05-15 | 0.15 | -1.05 | 24.93M | 400.00K |
| 2023-03-30 | -0.05 | -1.57 | 794.00K | 400.00K |
| 2022-11-23 | -2.40 | -1.50 | 29.17M | — |
| 2022-08-15 | 24.60 | -3.67 | 43.85M | 797.00K |
| 2022-05-09 | -6.90 | -6.85 | 794.00K | 797.00K |
| 2022-03-31 | -0.65 | -8.81 | 2.44M | 166.67K |
| 2021-11-12 | -0.80 | -9.90 | 2.30M | 675.00K |
| 2021-08-05 | -0.64 | -10.43 | 1.13M | 333.33K |
| 2021-05-06 | -0.79 | -8.66 | 1.47M | 1.07M |
| 2021-03-04 | -0.85 | -12.10 | 2.03M | 2.10M |
| 2020-11-05 | -0.73 | -12.94 | 893.00K | 300.00K |
| 2020-08-06 | -0.96 | -5.47 | 1.66M | 7.95M |
| 2020-05-11 | -0.28 | 2.55 | 16.37M | 15.00M |
| 2020-02-20 | -1.13 | -17.32 | — | 450.00K |
| 2019-11-07 | -1.06 | -17.40 | — | 450.00K |
| 2019-08-01 | -1.15 | — | — | — |
| 2019-05-02 | -1.26 | — | — | — |
| 2019-03-08 | -0.91 | — | 6.00K | — |
| 2018-11-01 | -0.64 | — | — | — |
| 2018-08-02 | -0.54 | — | — | — |
| 2018-05-03 | -0.56 | — | 6.00K | — |
| 2018-03-19 | -1.26 | — | 318.00K | — |
| 2017-11-02 | -1.34 | — | 318.00K | — |
| 2017-08-03 | -2.53 | — | 111.00K | — |
| 2017-05-11 | -4.57 | — | 271.00K | — |
| 2017-03-08 | -4.68 | — | 71.00K | — |
Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.
Safety score 49/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 3 separate years. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2023-01-13 | $3.60 | 2023-01-05 | — | Quarterly |
| 2022-09-21 | $21.45 | 2022-09-06 | — | Quarterly |
| 2015-08-20 | $896.17 | — | — | Quarterly |
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Weston Claire | Buy | 40.00K | $6.11 | 244.40K |
| 2026-08-03 | Kirkby Maxwell | Buy | 40.00K | $6.11 | 244.40K |
| 2026-08-01 | Weston Claire | Other | 0 | — | — |
| 2026-08-01 | Kirkby Maxwell | Other | 0 | — | — |
| 2026-06-18 | Ye Weiguo | Sell | 3.00K | $0.75 | 2.25K |
| 2026-06-18 | Ye Weiguo | Buy | 3.00K | $0.75 | 2.25K |
| 2026-06-18 | Ye Weiguo | Sell | 3.00K | $6.35 | 19.05K |
| 2026-06-11 | Ye Weiguo | Sell | 2.80K | $0.75 | 2.10K |
| 2026-06-11 | Ye Weiguo | Buy | 2.80K | $0.75 | 2.10K |
| 2026-06-11 | Ye Weiguo | Sell | 2.80K | $6.17 | 17.28K |
| 2026-06-10 | Carmichael Gordon | Buy | 40.00K | $5.95 | 238.00K |
| 2026-06-10 | Epstein David M. | Buy | 40.00K | $5.95 | 238.00K |
| 2026-06-10 | Weng Dan | Buy | 40.00K | $5.95 | 238.00K |
| 2026-06-10 | Parry Renate | Buy | 40.00K | $5.95 | 238.00K |
| 2026-06-10 | Zhang Ping | Buy | 40.00K | $5.95 | 238.00K |
| 2026-06-10 | Nussbaum Rodney L | Buy | 40.00K | $5.95 | 238.00K |
| 2026-06-10 | Ye Weiguo | Sell | 5.00K | $0.75 | 3.75K |
| 2026-06-10 | Ye Weiguo | Buy | 5.00K | $0.75 | 3.75K |
| 2026-06-10 | Ye Weiguo | Sell | 5.00K | $6.24 | 31.20K |
| 2026-06-10 | Ye Weiguo | Sell | 6.42K | $0.75 | 4.81K |
| 2026-06-10 | Ye Weiguo | Buy | 6.42K | $0.75 | 4.81K |
| 2026-06-10 | Ye Weiguo | Sell | 6.42K | $6.21 | 39.86K |
| 2026-06-09 | Ye Weiguo | Sell | 3.00K | $0.75 | 2.25K |
| 2026-06-09 | Ye Weiguo | Sell | 3.00K | $6.15 | 18.45K |
| 2026-06-09 | Ye Weiguo | Sell | 14.50K | $0.75 | 10.88K |
| 2026-06-09 | Ye Weiguo | Buy | 14.50K | $0.75 | 10.88K |
| 2026-06-09 | Ye Weiguo | Sell | 14.50K | $6.14 | 89.03K |
| 2026-06-08 | Bergmann Joshua Benjamin | Buy | 50.00K | $6.05 | 302.50K |
| 2026-06-08 | Luo Ying | Buy | 120.00K | $6.05 | 726.00K |
| 2026-06-05 | Ye Weiguo | Sell | 15.40K | $0.75 | 11.55K |
| 2026-06-05 | Ye Weiguo | Buy | 15.40K | $0.75 | 11.55K |
| 2026-06-05 | Ye Weiguo | Sell | 15.40K | $6.40 | 98.57K |
| 2026-06-04 | Ye Weiguo | Sell | 19.57K | $0.75 | 14.68K |
| 2026-06-04 | Ye Weiguo | Buy | 19.57K | $0.75 | 14.68K |
| 2026-06-04 | Ye Weiguo | Sell | 19.57K | $6.13 | 119.99K |
| 2026-05-26 | Ye Weiguo | Sell | 4.00K | $0.75 | 3.00K |
| 2026-05-26 | Ye Weiguo | Buy | 4.00K | $0.75 | 3.00K |
| 2026-05-26 | Ye Weiguo | Sell | 4.00K | $6.10 | 24.40K |
| 2026-05-22 | Ye Weiguo | Sell | 3.50K | $0.75 | 2.62K |
| 2026-05-22 | Ye Weiguo | Buy | 3.50K | $0.75 | 2.62K |
| 2026-05-22 | Ye Weiguo | Sell | 3.50K | $6.08 | 21.28K |
| 2026-05-21 | Ye Weiguo | Sell | 12.82K | $0.75 | 9.62K |
| 2026-05-21 | Ye Weiguo | Buy | 12.82K | $0.75 | 9.62K |
| 2026-05-21 | Ye Weiguo | Sell | 12.82K | $6.15 | 78.84K |
| 2026-05-20 | Ye Weiguo | Sell | 9.40K | $0.75 | 7.05K |
| 2026-05-20 | Ye Weiguo | Buy | 9.40K | $0.75 | 7.05K |
| 2026-05-19 | Ye Weiguo | Sell | 9.12K | $0.75 | 6.84K |
| 2026-05-19 | Ye Weiguo | Buy | 9.12K | $0.75 | 6.84K |
| 2026-05-19 | Ye Weiguo | Sell | 9.12K | $6.37 | 58.09K |
| 2026-05-18 | Ye Weiguo | Sell | 200 | $0.75 | 150 |
| 2026-05-18 | Ye Weiguo | Buy | 200 | $0.75 | 150 |
| 2026-05-18 | Ye Weiguo | Sell | 200 | $6.62 | 1.32K |
| 2026-05-15 | Ye Weiguo | Sell | 13.10K | $0.75 | 9.82K |
| 2026-05-15 | Ye Weiguo | Buy | 13.10K | $0.75 | 9.82K |
| 2026-05-15 | Ye Weiguo | Sell | 13.10K | $6.65 | 87.11K |
| 2026-05-14 | Zhang Ping | Sell | 250.00K | $10.18 | 2.54M |
| 2026-05-14 | Ye Weiguo | Sell | 15.58K | $0.75 | 11.69K |
| 2026-05-14 | Ye Weiguo | Buy | 15.58K | $0.75 | 11.69K |
| 2026-05-14 | Ye Weiguo | Sell | 15.58K | $6.91 | 107.66K |
| 2026-05-06 | Luo Ying | Sell | 10.14K | $8.04 | 81.49K |
| 2026-05-05 | Luo Ying | Sell | 179 | $8.01 | 1.43K |
| 2026-05-04 | Bergmann Joshua Benjamin | Other | 47.53K | $8.09 | 384.52K |
| 2026-05-04 | Wang Jialiang (NMN) | Other | 95.06K | $0.32 | 30.42K |
| 2026-05-04 | Wang Jialiang (NMN) | Other | 38.02K | $0.93 | 35.36K |
| 2026-05-04 | Wang Jialiang (NMN) | Other | 42.78K | $2.00 | 85.55K |
| 2026-05-04 | Wang Jialiang (NMN) | Other | 47.53K | $5.98 | 284.23K |
| 2026-05-04 | Xiong Yue | Other | 2.38M | — | — |
| 2026-05-04 | Luo Ying | Other | 0 | — | — |
| 2026-05-04 | Luo Ying | Other | 475.30K | $0.32 | 152.10K |
| 2026-05-04 | Luo Ying | Other | 237.65K | $0.93 | 221.01K |
| 2026-05-04 | Luo Ying | Other | 2.26M | $0.75 | 1.70M |
| 2026-05-04 | Luo Ying | Other | 235.27K | $5.98 | 1.41M |
| 2026-05-04 | Luo Ying | Other | 988.62K | $2.00 | 1.98M |
| 2026-05-04 | GNI Group Ltd. | Buy | 2.14M | — | — |
| 2026-05-04 | GNI Group Ltd. | Buy | 458.12K | — | — |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 95.06K | $0.32 | 30.42K |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 95.06K | $2.34 | 222.44K |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 92.68K | $5.98 | 554.24K |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 47.53K | $0.93 | 44.20K |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 33.27K | $2.00 | 66.54K |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 33.27K | $0.32 | 10.65K |
| 2026-05-04 | Eastling Thomas Wilson | Buy | 11.88K | $2.00 | 23.76K |
| 2026-01-07 | Zhang Ping | Buy | 100.00K | $7.31 | 731.00K |
| 2026-01-07 | Chen Ruoyu | Buy | 50.00K | $7.31 | 365.50K |
| 2025-08-18 | Weng Dan | Buy | 52.00K | $7.85 | 408.20K |
| 2025-08-18 | Weng Dan | Other | 0 | — | — |
| 2025-08-05 | Zhang Ping | Buy | 250.00K | $6.92 | 1.73M |
| 2025-06-04 | Eastling Thomas Wilson | Buy | 26.00K | $8.58 | 223.08K |
| 2025-06-04 | Epstein David M. | Buy | 26.00K | $8.58 | 223.08K |
| 2025-06-04 | Nussbaum Rodney L | Buy | 26.00K | $8.58 | 223.08K |
| 2025-06-04 | Parry Renate | Buy | 26.00K | $8.58 | 223.08K |
| 2025-06-04 | Carmichael Gordon | Buy | 26.00K | $8.58 | 223.08K |
| 2025-05-28 | Ma Songjiang | Sell | 558 | $10.07 | 5.62K |
| 2025-05-27 | Ma Songjiang | Sell | 2.00K | $10.28 | 20.56K |
| 2025-05-27 | Zhang Ping | Buy | 250.00K | $10.18 | 2.54M |
| 2025-05-23 | Ma Songjiang | Sell | 182 | $10.24 | 1.86K |
| 2025-05-22 | Ma Songjiang | Sell | 2.00K | $10.97 | 21.94K |
| 2025-05-21 | Ma Songjiang | Sell | 2.00K | $10.83 | 21.66K |
| 2025-05-20 | Ma Songjiang | Sell | 2.00K | $11.25 | 22.50K |
| 2025-05-19 | Ma Songjiang | Sell | 2.00K | $11.11 | 22.22K |
Latest filed quarter: Q2 2026.
Institutions holding: 62, holders +7 vs prior quarter. Ownership 9.69%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| HSG HOLDING LTD | 3.75M | 3.75M | New | 24.71M |
| BLACKROCK, INC. | 993.94K | 235.31K | +31.02% | 6.55M |
| OCTAGON CAPITAL ADVISORS LP | 954.42K | 954.42K | New | 6.29M |
| VANGUARD CAPITAL MANAGEMENT LLC | 876.93K | -107.28K | -10.90% | 5.78M |
| GEODE CAPITAL MANAGEMENT, LLC | 532.95K | 101.54K | +23.54% | 3.51M |
| STATE STREET CORP | 245.40K | 29.08K | +13.44% | 1.62M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 184.29K | 19.05K | +11.53% | 1.21M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 184.29K | 184.29K | New | 1.21M |
| NORTHERN TRUST CORP | 169.54K | 35.70K | +26.67% | 1.12M |
| SBI SECURITIES CO., LTD. | 166.75K | -4.09K | -2.39% | 1.10M |
| VANGUARD FIDUCIARY TRUST CO | 151.07K | 13.39K | +9.73% | 995.57K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 123.95K | 54.14K | +77.55% | 816.85K |
| GOLDMAN SACHS GROUP INC | 86.23K | 13.11K | +17.93% | 568.29K |
| BANK OF NEW YORK MELLON CORP | 62.75K | 19.61K | +45.44% | 413.52K |
| MORGAN STANLEY | 41.69K | 33.05K | +382.48% | 274.74K |
| ALLIANCEBERNSTEIN L.P. | 24.59K | 2.76K | +12.64% | 171.39K |
| STRS OHIO | 25.80K | 4.70K | +22.27% | 170.02K |
| DIMENSIONAL FUND ADVISORS LP | 25.27K | 0 | 0.00% | 166.52K |
| NUVEEN, LLC | 24.50K | 24.50K | New | 161.49K |
| UBS GROUP AG | 18.76K | -2.32K | -11.02% | 123.65K |
| MILLENNIUM MANAGEMENT LLC | 18.49K | 18.49K | New | 121.84K |
| DEUTSCHE BANK AG\ | 17.94K | 7.33K | +69.03% | 118.22K |
| RHUMBLINE ADVISERS | 16.86K | 3.75K | +28.58% | 111.13K |
| WELLS FARGO & COMPANY/MN | 16.30K | 12.01K | +279.88% | 107.40K |
| PRICE T ROWE ASSOCIATES INC /MD/ | 15.03K | 15.03K | New | 100.00K |
Gyre Therapeutics, Inc. (GYRE) trades at $7.05, with a market cap of $747.97M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$747.97M
Market Cap
—
P/E
—
Forward P/E
58
Score